Stock PSYB.H PSYBIO THERAPEUTICS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages PsyBio Therapeutics Corp.

Equities

PSYB.H

CA6936971044

Delayed Toronto S.E.
Other stock markets
 09:54:13 29/03/2024 am IST 		5-day change 1st Jan Change
0.01 CAD -.--% Intraday chart for PsyBio Therapeutics Corp. -.--% -.--%
2021 PsyBio Therapeutics Files Patent Application with USPTO for Production Methods of Methylated Trypatamines and Associated Analogs CI
2021 PsyBio Therapeutics : Files Novel Psychedelic Compositions and Methods of Treatment Patent With USPTO MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PsyBio Therapeutics : Files Novel Psychedelic Compositions and Methods of Treatment Patent With USPTO
IRW-News: PsyBio Therapeutics Corp.: PsyBio Therapeutics beruft erfahrene pharmazeutische Führungskraft Bob Oliver in sein Board of Directors
PsyBio Therapeutics : Strengthens Leadership Team with Appointment of Dr. Michael Spigarelli as Chief Medical Officer
IRW-News: PsyBio Therapeutics Corp.: PsyBio Therapeutics beginnt mit Prozessentwicklung von eigenem biosynthetischem Norbaeocystin
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PSYB.H Stock
  4. News PsyBio Therapeutics Corp.
  5. Other languages
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW